<unk>  is more likely to recur within the first five years after treatment than other breast cancers. However, after five years the chance of recurrence is much less than for other breast cancers. The risk of recurrence peaks at three years from diagnosis and reduces after that. Cancer survival is typically based on 5-year survival rates which is the survival rate compared to women without breast cancer and is based on the stage when the cancer is first diagnosed. These statistics do not apply if the cancer returns after treatment. + Survival rates for<unk>  from time of diagnosis stage 5-year survival Localised 91% Regional 65% Distant 12% All stages 77% Approximately 25% of those with localised disease will relapse with distant metastasis also known as stage IV. Median survival from diagnosis of metastasis is around 12 months. Metastasis in<unk>  is different from other breast cancers with a tendency to spread to the brain and other organs such as lungs and liver and there is less of a tendency to spread to bones.
Triple-negative breast cancer
Hereditary lobular breast cancer
Hormone receptor positive breast tumor
Paget's disease of the breast
Mucinous carcinoma of the breast
Medullary breast carcinoma
Inflammatory breast cancer
Hormone-sensitive cancer